Reduction of circulating 25-hydroxyvitamin D by antipyrine. 1979

P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park

1 Twenty-four Asian vegetarians had significantly lower 25-hydroxyvitamin D (25-OHD) levels and longer antipyrine half-lives than twenty white non-vegetarians (P less than 0.001). 2 Treatment with oral antipyrine over 4 or 5 weeks in seven vegetarian Asians and five racially different non-vegetarians increased drug oxidation significantly in both groups as measured by a fall in antipyrine half-lives and a rise in serum gamma-glutamyltranspeptidase levels and urinary 6 beta-hydroxycortisol/17-hydroxycorticosteroid ratios. 3 Antipyrine treatment produced a fall in circulating 25-hydroxyvitamin D of around 60% in all subjects in whom pretreatment levels could be measured, independent of race and diet. 4. In the Caucasian non-vegetarian group 1,25 dihidroxyvitamin D levels, the most active metabolite of vitamin D, were also measured and remained unaltered despite a substantial fall in 25-hydroxy substrate. 5 The acute fall in 25-hydroxyvitamin D concentration with a maintained level of 1,25 dihidroxyvitamin D may represent the early changes of drug-induced osteomalacia.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D005260 Female Females
D006113 United Kingdom Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. Great Britain,Isle of Man
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park
January 1976, Revue du rhumatisme et des maladies osteo-articulaires,
P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park
July 1974, The American journal of medicine,
P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park
July 2013, European journal of epidemiology,
P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park
April 2016, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park
May 2004, The Journal of steroid biochemistry and molecular biology,
P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park
August 2015, Practical laboratory medicine,
P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park
January 2013, Genetic epidemiology,
P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park
August 2010, The Journal of steroid biochemistry and molecular biology,
P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park
December 2008, Oncology reports,
P F Wilmana, and M J Brodie, and J C Mucklow, and H S Fraser, and E L Toverud, and D S Davies, and C T Dollery, and C J Hillyard, and I Macintyre, and B K Park
December 2018, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
Copied contents to your clipboard!